cjc 1295
Regeneration vs degeneration — where this fits
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
This topic: Growth-hormone secretagogues are studied for metabolic and tissue maintenance pathways — anabolic/regenerative signaling vs age-related decline.
What it is
2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use.
How it works
From preclinical claims (animal/lab — not human proof):
- 2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use.
Why it would work (logic chain)
- IF 2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
How many people take it
There is no reliable global count of how many people take this compound. That number is not in this ledger.
What we can count from this ledger:
- 0 anecdote source(s) (posts, threads, comments)
- 0 anecdote-tier claim(s) derived from them
Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.
Evidence inventory
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 1
- Claims tagged human evidence: 0
- Claims tagged preclinical (animal/lab): 1
- Claims tagged anecdotal: 0
- Reddit posts catalogued: 0
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 1
Logic: Studies exist in the ledger, but none are graded as strong human proof for the uses people discuss online. Animal and lab work is not the same as proof in people.
Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.
Quantified confidence (this ledger): 0.07 / 1.00 — very low
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians (source s1)
2026 narrative review of therapeutic peptides including CJC-1295 + ipamorelin; notes preclinical animal data only for muscle effects and emphasizes overall lack of human clinical evidence for orthopaedic/sports use.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Ask this article · 3 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.